docetaxel anhydrous has been researched along with Cancer of Penis in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 8 (80.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Arakawa, Y; Arita, T; Asai, J; Inoue, M; Kaneko, Y; Kanemaru, M; Katoh, N; Kondo, J; Matsui, M; Tsutsumi, M | 1 |
Bunger, D; Gupta, S; Pawar, SS | 1 |
Boito, R; Bova, F; Colombo, AF; Greco, S; LucĂ , R; Rizzuto, G; Sellaro, A | 1 |
Cai, QL; Li, G; Niu, YJ; Wang, Z; Xu, J; Yang, X; Zhang, HT; Zhu, SM | 1 |
Bahl, A; Barber, J; Burnett, S; Carrington, B; Chester, JD; Cruickshank, C; Elliott, T; Hall, E; Harland, SJ; Nicholson, S; Pickering, L; Thomson, A; Waters, R | 1 |
Bergman, AM; Djajadiningrat, RS; Horenblas, S; van Werkhoven, E; Vegt, E | 1 |
Ye, D; Zhang, S; Zhu, Y | 1 |
Dai, B; Mao, HR; Shen, YJ; Yao, XD; Ye, DW; Zhang, HL; Zhang, SL; Zhu, Y | 1 |
Catanzaro, M; Colecchia, M; Necchi, A; Nicolai, N; Piva, L; Salvioni, R; Torelli, T | 1 |
Buonerba, C; D'Aniello, C; Damiano, V; De Placido, S; Di Lorenzo, G; Di Trolio, R; Federico, P; Mainolfi, C; Matano, E; Palmieri, G; Raimondo, L; Rescigno, P | 1 |
2 trial(s) available for docetaxel anhydrous and Cancer of Penis
Article | Year |
---|---|
Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Docetaxel; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Penile Neoplasms; Survival Analysis; Taxoids; United Kingdom | 2013 |
Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; China; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Palliative Care; Penile Neoplasms; Proportional Hazards Models; Taxoids; Time Factors; Treatment Outcome | 2015 |
8 other study(ies) available for docetaxel anhydrous and Cancer of Penis
Article | Year |
---|---|
Novel ex vivo disease model for extramammary Paget's disease using the cancer tissue-originated spheroid method.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Culture Media; Docetaxel; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Intercellular Signaling Peptides and Proteins; Male; Paget Disease, Extramammary; Penile Neoplasms; Primary Cell Culture; Skin Neoplasms; Spheroids, Cellular; Tumor Cells, Cultured; Vulvar Neoplasms; Xenograft Model Antitumor Assays | 2020 |
Successful downstaging of locally recurrent penile squamous cell carcinoma with neoadjuvant nanosomal docetaxel lipid suspension (NDLS) based regimen followed by curative surgery.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Penile Neoplasms; Penis; Taxoids; Tomography, X-Ray Computed | 2017 |
[Atypical Hemolitic Uremic Syndrome after administration of Docetaxel].
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Atypical Hemolytic Uremic Syndrome; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Humans; Lymph Node Excision; Male; Middle Aged; Penile Neoplasms; Plasma; Postoperative Complications; Renal Dialysis; Taxoids | 2018 |
Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Docetaxel; Humans; Ifosfamide; Inguinal Canal; Kaplan-Meier Estimate; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Penile Neoplasms; Penis; Taxoids | 2019 |
Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Penile Neoplasms; Positron-Emission Tomography; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget's disease.
Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Cadherins; Docetaxel; Female; Fluorouracil; Genital Neoplasms, Male; Humans; Male; Middle Aged; Neoplasm Invasiveness; Paget Disease, Extramammary; Penile Neoplasms; Scrotum; Survival Analysis; Taxoids | 2009 |
Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis.
Topics: Amputation, Surgical; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Administration Schedule; ErbB Receptors; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Panitumumab; Penile Neoplasms; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Combination of docetaxel and cetuximab for penile cancer: a case report and literature review.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Docetaxel; Drug Administration Schedule; Fluorodeoxyglucose F18; Humans; Male; Penile Neoplasms; Positron-Emission Tomography; Taxoids; Treatment Outcome | 2012 |